Journal of Personalized Medicine · 2024 · 38 citations · 46 references
Life SciencesNeurobiologyPsychiatryMolecular NeurobiologyNanobiotechnologyPsychopharmacologyGut MicrobiomeGut MicrobiotaMicrobiome DysbiosisMicrobiome FunctionMicrobiome TherapeuticsNanomedicineGut Microbiome AlterationsGut Microbiome DysbiosisGut-brain Axis SignalingMicrobiome-gut-brain AxisMicrobiome-gut-brain CommunicationMicrobiome-targeted TherapyMicrobiota-gut-brain AxisMicrobiota-targeted Therapy
The prevalence of schizophrenia, affecting approximately 1% of the global population, underscores the urgency for innovative therapeutic strategies. Recent insights into the role of neuroinflammation, the gut-brain axis, and the microbiota in schizophrenia pathogenesis have paved the way for the exploration of psychobiotics as a novel treatment avenue. These interventions, targeting the gut microbiome, offer a promising approach to ameliorating psychiatric symptoms. Furthermore, advancements in artificial intelligence and nanotechnology are set to revolutionize psychobiotic development and application, promising to enhance their production, precision, and effectiveness. This interdisciplinary approach heralds a new era in schizophrenia management, potentially transforming patient outcomes and offering a beacon of hope for those afflicted by this complex disorder.
46
Schizophrenia: overview and treatment options.
Krishna Patel, Jessica Cherian, Kunj Gohil et al. · PubMed · 2014 · 360 citations
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders
John A. Williams, Stephen Burgess, John Suckling et al. · JAMA Psychiatry · 2022 · 297 citations · Full text
Medicine, Neuroscience, Psychiatry +17